No Data
ChemPartner PharmaTech (300149.SZ): Projected loss of 0.193 billion yuan to 0.25 billion yuan for the year 2024.
On January 24, Gelonghui reported that ChemPartner PharmaTech (300149.SZ) announced its performance forecast for 2024. The net income attributable to shareholders of the listed company is expected to be a loss of 0.193 billion yuan to 0.25 billion yuan, and the net income after deducting non-recurring gains and losses is expected to be a loss of 0.2 billion yuan to 0.26 billion yuan. In 2024, due to the continuous impact of changes in market demand and other factors, the operation performance of the company's wholly owned subsidiary Shanghai ChemPartner PharmaTech Research Group Co., Ltd. did not meet expectations, and there are signs of goodwill impairment. Based on the actual operating conditions and in accordance with the "Accounting Standards for Enterprises No. 8 – Asset Impairment" and relevant accounting policies, the company...
Smart Pharmaceuticals: 2024 Annual Results Forecast
ChemPartner PharmaTech Co.,Ltd. (SZSE:300149) Not Doing Enough For Some Investors As Its Shares Slump 28%
Case Against Chempartner Pharmatech Chair Dropped
Chempartner Pharmatech to Issue Up to 931 Million Yuan of Shares
ChemPartner PharmaTech (300149.SZ): The actual controller will change to WOO SWEE LIAN.
On December 13, 2023, Glonghui reported that ChemPartner PharmaTech (300149.SZ) announced, according to the Civil Mediation Document No. (2024) Yue 07 Min Chu 66 issued by the Intermediate People's Court of Jiangmen City, Guangdong Province, that the company's shareholder Beihai Baben Venture Capital Co., Ltd. agrees to transfer 30,033,098 shares of ChemPartner PharmaTech held by Beihai Baben Venture Capital Co., Ltd. to Mr. WOO SWEE LIAN within fifteen days starting from the effective date of the mediation document (November 27, 2024), and to complete the transfer registration procedures, with the transfer price based on the day before the mediation document takes effect.
Chempartner Pharmatech Co., Ltd.'s (SZSE:300149) Share Price Boosted 31% But Its Business Prospects Need A Lift Too
